Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The nature of
kinesin
interactions with membrane-bound organelles and mechanisms for regulation of
kinesin
-based motility have both been surprisingly difficult to define. Most
kinesin
is recovered in supernatants with standard protocols for purification of motor proteins, but
kinesin
recovered on membrane-bound organelles is tightly bound. Partitioning of
kinesin
between vesicle and cytosolic fractions is highly sensitive to buffer composition. Addition of either N-ethylmaleimide or EDTA to homogenization buffers significantly increased the fraction of
kinesin
bound to organelles. Given that an antibody against kinesin light chain tandem repeats also releases
kinesin
from vesicles, these observations indicated that specific cytoplasmic factors may regulate
kinesin
release from membranes. Kinesin light tandem repeats contain DnaJ-like motifs, so the effects of
hsp70
chaperones were evaluated. Hsc70 released
kinesin
from vesicles in an MgATP-dependent and N-ethylmaleimide-sensitive manner. Recombinant
kinesin
light chains inhibited
kinesin
release by hsc70 and stimulated the hsc70 ATPase. Hsc70 actions may provide a mechanism to regulate
kinesin
function by releasing
kinesin
from cargo in specific subcellular domains, thereby effecting delivery of axonally transported materials.
...
PMID:Release of kinesin from vesicles by hsc70 and regulation of fast axonal transport. 1084 36